Ketotifen Help

Ketotifen, the active ingredient in Ketotifen Help, is a mast cell stabilizer presented as an oral tablet for oral administration. It reduces the release of histamine and other inflammatory mediators, making it useful for treating allergic rhinitis, allergic conjunctivitis, and for prophylactic management of asthma symptoms in patients prone to allergic triggers.

GNH USA supplies Ketotifen Help as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under strict quality standards and ensuring regulatory compliance in each market.

Ketotifen is indicated for allergic disorders that involve mast cell activation.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and watery discharge caused by seasonal or perennial allergens. Allergic conjunctivitis: alleviates ocular itching, redness, swelling and tearing that occur during allergic eye reactions. Asthma prophylaxis: helps prevent bronchospasm, airway hyper‑responsiveness and inflammatory episodes in patients with allergic asthma when used as a preventive therapy.

Ketotifen may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: reduced salivation leading to a dry oral cavity. - Weight gain: modest increase in body weight with prolonged use. - Gastrointestinal discomfort: nausea, abdominal pain or dyspepsia.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention. - Hepatotoxicity: signs of liver injury such as jaundice, dark urine or elevated enzymes. - Cardiac arrhythmia: rare reports of irregular heart rhythm.

Before initiating Ketotifen therapy, consider the following precautions to ensure safe use.

- Assess medical history: identify existing liver disease, asthma severity or cardiac conditions. - Monitor sedation: advise patients about possible drowsiness affecting driving or machinery operation. - Caution in the elderly: increased sensitivity to central nervous system effects may occur. - Pregnancy and lactation: use only if the potential benefit outweighs the unknown risk. - Concomitant CNS depressants: avoid or adjust dose when combined with other sedating agents. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Ketotifen can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: concurrent use may increase risk of hypertensive crisis. - Anticholinergic drugs: combined effect can exacerbate dry mouth and urinary retention.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, antihistamines): may enhance sedation and impair psychomotor performance. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise ketotifen plasma levels, requiring dose adjustment. - Beta‑agonist inhalers: monitor asthma control as ketotifen may affect bronchodilator response.